VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into Corcept Therapeutics Incorporated (CORT) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceuticals · market value about $8.9B · P/E 195.1 · revenue $831M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows